How Moderna Won the Vaccine Wars
Traders looking to invest in vaccine stocks faced a difficult decision at the start of the vaccine rollout in late 2020 and early 2021: which vaccine stock would be the best bet in the months and years to come? With Pfizer and BioNTech, Johnson & Johnson and Moderna all becoming available at once, there was no way to know for sure which investment would yield the greatest returns.